Overview

Safety and Efficacy of ALC in Breast Cancer in Subjects With Fatigue

Status:
Terminated
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of ALC in the treatment of non-anemic, breast cancer subjects who develop moderate or severe fatigue during adjuvant radiotherapy.
Phase:
Phase 2
Details
Lead Sponsor:
Sigma-Tau Research, Inc.